L. O'Connor

BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients.

S. Langabeer, S. McCarron, E. Conneally, 2013, Genetic testing and molecular biomarkers.

Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo

G. Campiani, D. Williams, D. Zisterer, 2010, British Journal of Cancer.

Restoration of donor chimerism by nilotinib in a chronic myeloid leukaemia patient post mutation-associated imatinib mesylate resistance and allogeneic stem cell transplant failure

S. Langabeer, S. McCann, E. Conneally, 2008, Bone Marrow Transplantation.

The Vascular Targeting Agent Combretastatin-A4 and a Novel cis-Restricted β-Lactam Analogue, CA-432, Induce Apoptosis in Human Chronic Myeloid Leukemia Cells and Ex Vivo Patient Samples Including Those Displaying Multidrug Resistance

D. Zisterer, L. Greene, M. Meegan, 2010, Journal of Pharmacology and Experimental Therapeutics.

In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer

T. Murphy, D. Hollywood, A. Perry, 2011, The Prostate.